EMS Find Inc (OTCMKTS:EMSF) reported that it intends to expand its EMS Find Application by beginning development of the on-demand mobile platform known as ‘RN Find.’ It is designed to connect home care agencies, nursing homes, hospitals, and many other health care provider units with nursing experts who are looking for additional employment. It is also meant to help patients seeking for help with sub-acute and post-acute health care.
In the era of Affordable Care Act, a vast migration of registered nurses is happening from conventional clinical settings to case management. The new segment wants nurses take on a much larger role, quite similar to that of primary physicians. In present scenario, on demand mobile applications have become a strategic must for health care providers to effectively compete in rapidly changing mobile era.
The CEO of EMS Find, Mr. Steve Rubakh said that by bundling and jointly commercializing the RN Find and the EMS Find, the company is targeting what is expected to be a $119 billion annual labor market by year 2022. It is projected that the segment will have total 3.5 million nurses employed at major nursing homes, hospitals and home care agencies. EMS Find focus is on developing an innovative and unique B2C and B2B real time platform in order to provide the highest level of health care.
As per a Georgetown University Center report, the economy will create nearly 1.6million employment opportunities for nurses through 2020. The report highlighted that there would be the number of nurses would not be enough to fill these openings. As per the report, there will be shortage of 193,000 nursing professionals.
EMS Find Inc (OTCMKTS:EMSF) ended the last trading session almost flat as it closed with minor loss of 0.87%. What the final closing price of $1.2590 or the day’s loss didn’t reflect was the solid intraday recovery from the day low, more than 10%. The stock has been moving sideways for the last few weeks and trying to make a base. It has tested the area around $1.00 multiple times and the last test pushed the price up. The price action in the recent days indicates a continuation of the sideways phase, probably in the range of $1.00-$1.35.